LONDON BROKER RATINGS: UBS raises AstraZeneca to ’buy’

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

----------

FTSE 100

----------

Goldman Sachs raises ConvaTec price target to 310 (300) pence - ’buy’

----------

UBS raises AstraZeneca to ’buy’ (neutral) - price target 14,200 (11,500) pence

----------

JPMorgan places Smiths Group on ’positive catalyst watch’

----------

JPMorgan cuts Smiths Group price target to 2,420 (2,440) pence - ’overweight’

----------

Bank of America raises Informa price target to 1,100 (1,075) pence - ’buy’

----------

FTSE 250

----------

Morgan Stanley raises AJ Bell price target to 430 (360) pence - ’underweight’

----------

Barclays cuts Bellway price target to 3,025 (3,077) pence - ’overweight’

----------

Peel Hunt raises Bellway to ’add’ (hold) - price target 3,000 (3,160) pence

----------

SMALL CAP AND OTHER MAIN MARKET

----------

Berenberg cuts Pan African Resources price target to 39 (42) pence - ’buy’

----------

Barclays raises Smurfit WestRock target to 5,450 (5,325) pence - ’overweight’

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.